Rubicon Research Stock Screener | Share Price & Fundamental Analysis
RUBICON
Pharmaceuticals
Screen Rubicon Research share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹692.90
▲
28.40 (4.27%)
Share Price BSE
₹693.60
▲
30.15 (4.54%)
Market Cap
₹11,145.36 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
10.69
EPS (TTM)
₹8.82
Dividend Yield
-
Debt to Equity
0.91
52W High
₹742.10
52W Low
₹577.25
Operating Margin
23.00%
Profit Margin
13.08%
Revenue (TTM)
₹413.00
EBITDA
₹95.00
Net Income
₹54.00
Total Assets
₹1,451.00
Total Equity
₹541.00
Rubicon Research Share Price History - Stock Screener Chart
Screen RUBICON historical share price movements with interactive charts. Analyze price trends and patterns.
Rubicon Research Company Profile - Fundamental Screener
Screen Rubicon Research company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for RUBICON shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE506V01022
Rubicon Research Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen RUBICON balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 1,451 | 1,110 | 750 | 560 | 538 | 430 |
| Current Assets | 1,063 | 763 | 502 | 328 | 340 | 265 |
| Fixed Assets | 327 | 307 | 199 | 193 | 188 | 157 |
| Liabilities | ||||||
| Total Liabilities | 1,451 | 1,110 | 750 | 560 | 538 | 430 |
| Current Liabilities | 124 | 152 | 102 | 71 | 53 | 12 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 541 | 385 | 286 | 305 | 374 | 341 |
| Share Capital | 15 | 15 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 526 | 370 | 281 | 300 | 369 | 335 |
Screen RUBICON income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2024-Sept | 2024-Jun |
|---|---|---|---|---|
| Revenue | 413 | 353 | 299 | 317 |
| Expenses | 318 | 273 | 234 | 257 |
| EBITDA | 95 | 80 | 64 | 61 |
| Operating Profit % | 23.00% | 22.00% | 21.00% | 19.00% |
| Depreciation | 12 | 10 | 8 | 9 |
| Interest | 11 | 11 | 7 | 10 |
| Profit Before Tax | 72 | 60 | 49 | 41 |
| Tax | 18 | 16 | 15 | 16 |
| Net Profit | 54 | 43 | 35 | 26 |
| EPS | 3.49 | 2.81 | 2.27 | 1.66 |
Rubicon Research Cash Flow Screener - Liquidity Fundamentals
Screen RUBICON cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 159 | 21 | -75 | -63 | 62 | 6 |
| Investing Activities | -65 | -68 | -32 | -46 | -46 | -84 |
| Financing Activities | -40 | 44 | 123 | 63 | 52 | 80 |
| Net Cash Flow | 54 | -4 | 16 | -46 | 67 | 1 |
Screen RUBICON shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Oct | 2024-Jul |
|---|---|---|---|
| Promoter Holding | 59.99% | 59.99% | 84.15% |
| FII Holding | 9.37% | 9.37% | 0.00% |
| DII Holding | 10.54% | 10.54% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.28% | 18.28% | 0.00% |
| Other Holding | 1.82% | 1.82% | 15.85% |
| Shareholder Count | 105,311 | 105,311 | 15 |
Rubicon Research Dividend Screener - Share Yield Analysis
Screen RUBICON dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.02 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Rubicon Research Index Membership - Market Screener Classification
Screen RUBICON by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Rubicon Research Market Events Screener - Corporate Actions
Screen RUBICON market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -1.76% |
Rubicon Research Competitors Screener - Peer Comparison
Screen RUBICON competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,950 | 39.35 | 54,729 | 9.71% | 10,980 | 39.47 |
| Divis Laboratories | 168,413 | 68.31 | 9,712 | 18.67% | 2,191 | 44.14 |
| Torrent Pharmaceuticals | 130,247 | 60.76 | 11,539 | 6.99% | 1,911 | 62.90 |
| Cipla | 121,238 | 22.46 | 28,410 | 7.12% | 5,291 | 46.90 |
| Dr Reddys Laboratories | 104,613 | 18.49 | 33,741 | 16.73% | 5,725 | 43.77 |
| Lupin | 96,056 | 22.19 | 22,910 | 13.74% | 3,306 | 55.44 |
| Zydus Life Science | 92,075 | 18.30 | 23,511 | 18.55% | 4,615 | 44.07 |
| Mankind Pharma | 89,356 | 51.11 | 12,744 | 20.90% | 2,007 | 44.20 |
| Aurobindo Pharma | 69,290 | 20.05 | 32,346 | 9.43% | 3,484 | 49.09 |
| Alkem Laboratories | 65,324 | 27.31 | 13,458 | 3.70% | 2,216 | 38.49 |
Rubicon Research Company Announcements - News Screener
Screen RUBICON latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-05 | Closure of Trading Window | View |
| 2025-12-08 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-20 | Intimation For Updation Of Corporate Identification Number ("CIN") Of The Company | View |
| 2025-11-18 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-14 | Newspaper Publication - Financial Results | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Thursday 13Th November 2025 | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-13 | Results-Financial Results For 30-09-2025 | View |
| 2025-11-13 | Reporting Of Violations Under SEBI (Prohibition Of Insider Trading) Regulations 2015. | View |
| 2025-11-08 | Newspaper Publication - Notice Of Postal Ballot | View |
| 2025-11-07 | Notice Of Postal Ballot | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-07 | Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday 13Th November 2025. | View |
| 2025-10-28 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-10-21 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-10-17 | Closure of Trading Window | View |
| 2025-10-16 | Listing of Equity Shares of Rubicon Research Ltd | - |